000 00907 a2200253 4500
005 20250514084429.0
264 0 _c20030501
008 200305s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(53)90885-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGALTON, D A
245 0 0 _aMyleran in chronic myeloid leukaemia; results of treatment.
_h[electronic resource]
260 _bLancet (London, England)
_cJan 1953
300 _a208-13 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBusulfan
650 0 4 _aGlycols
_xtherapeutic use
650 0 4 _aLeukemia
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
650 0 4 _aLeukemia, Myeloid
_xtherapy
773 0 _tLancet (London, England)
_gvol. 264
_gno. 6753
_gp. 208-13
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(53)90885-x
_zAvailable from publisher's website
999 _c12865050
_d12865050